JANTSEN BRISTOW: Open Payments
NPI 1932622859 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 47 payments from 13 companies in 2025. Trend: 2023 $1,257 · 2024 $1,660 · 2025 $1,289
Food & beverage: $1,280Education: $10
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 6 | $303 |
| ABBVIE INC. | 13 | $201 |
| Novartis Pharmaceuticals Corporation | 3 | $181 |
| LEO Pharma Inc. | 2 | $166 |
| Lilly USA, LLC | 5 | $81 |
| UCB, Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $63 |
| Incyte Corporation | 2 | $50 |
| Janssen Biotech, Inc. | 3 | $44 |
Products named: NEMLUVIO, Rhapsido, RINVOQ, SKYRIZI, TALTZ, Bimzelx, DUPIXENT, Sotyktu.
Industry payments across MO — which companies pay providers there.
